RxDoctor Payments Data

Bharat Shah, MD

Family Medicine · Chicago, ILNPI 1316971005

Payments from drug & device makers

$599in general payments, 2019–2025

Across 31 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$228
  • Sumitomo Pharma America, Inc.$143
  • Lilly USA, LLC$122
  • Teva Pharmaceuticals USA, Inc.$38
  • UCB, Inc.$28
  • Johnson & Johnson$25
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$599100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$599 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$222,053
Medicare patients
337
Services billed
2,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate64$196,827
JanuviaSitagliptin Phosphate671$152,695
EliquisApixaban332$78,517
IngrezzaValbenazine Tosylate25$60,822
JardianceEmpagliflozin214$58,419
Breo ElliptaFluticasone/Vilanterol122$52,606
AptiomEslicarbazepine Acetate73$51,615
TradjentaLinagliptin270$51,437
XareltoRivaroxaban203$48,831
TrulicityDulaglutide53$34,221
PrezcobixDarunavir/Cobicistat14$32,481
DescovyEmtricitabine/Tenofov Alafenam14$29,019
Atorvastatin Calcium2,808$25,754
Risperidone ErRisperidone Microspheres22$23,509
Chlorpromazine Hcl186$21,100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Xarelto, Prezcobix, Risperdal Consta$25$298,061300 claims
Sunovion Pharmaceuticals Inc.Aptiom$228$51,61573 claims
Lilly USA, LLCTrulicity, Olanzapine$122$43,049463 claims
Sumitomo Pharma America, Inc.Gemtesa$143$10,52655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →